Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

PU.1-Induced IRF4 Down-Regulation and Subsequent IRF7 up-Regulation in Myeloma Cells

Niina Ueno, MD, Shikiko Ueno, MD PhD, Shinya Endo, MD, Nao Nishimura, MD, Hiro Tatetsu, MD PhD, Shinya Hirata, MD PhD, Hiroaki Mitsuya, MD PhD, Yutaka Okuno, MD PhD

Blood (2015) 126 (23): 2957.

https://doi.org/10.1182/blood.V126.23.2957.2957

Published: 2015

Journal Articles

Conditional Knockout of Sfpi1 in Post GC B and Plasma Cells Induces B Cell Lymphoma and Plasma Cell Neoplasm

Shinya Endo, MD, Hiromichi Yuki, MD PhD, Yoshihiro Komohara, MD PhD, Shikiko Ueno, MD PhD, Nao Nishimura, MD, Niina Ueno, MD, Hiro Tatetsu, MD PhD, Motohiro Takeya, MD PhD, Hiroyuki Hata, MD PhD, Seiji Okada, MD PhD, Daniel G. Tenen, MD, Hiroaki Mitsuya, MD PhD, Yutaka Okuno, MD PhD

Blood (2014) 124 (21): 29.

https://doi.org/10.1182/blood.V124.21.29.29

Published: 2014

Journal Articles

Xenograft Models of Multiple Myeloma Reveal That PU.1 Serves As a Tumor Suppressor for Multiple Myeloma

Nao Nishimura, MD, Shinya Endo, MD, Niina Ueno, MD, Shikiko Ueno, MD PhD, Hiromichi Yuki, MD PhD, Hiroyuki Hata, MD PhD, Hiroaki Mitsuya, MD PhD, Yutaka Okuno, MD PhD

Blood (2014) 124 (21): 2047.

https://doi.org/10.1182/blood.V124.21.2047.2047

Published: 2014

Journal Articles

SALL4 Is a Key Factor in HDAC Inhibitor Mediated Ex Vivo Expansion of Human Peripheral Blood Mobilized Stem/Progenitor CD34+CD90+ Cells

Hiro Tatetsu, MD PhD, Fei Wang, Chong Gao, MD PhD, Shikiko Ueno, MD PhD, Xi Tian, BS, Myriam Armant, PhD, Alex Federation, Jun Qi, PhD, James E. Bradner, Daniel G. Tenen, MD, Li Chai, MD

Blood (2014) 124 (21): 1566.

https://doi.org/10.1182/blood.V124.21.1566.1566

Published: 2014

Journal Articles

PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cells

Hiromichi Yuki, Shikiko Ueno, Hiro Tatetsu, Hiroaki Niiro, Tadafumi Iino, Shinya Endo, Yawara Kawano, Yoshihiro Komohara, Motohiro Takeya, Hiroyuki Hata, Seiji Okada, Toshiki Watanabe, Koichi Akashi, Hiroaki Mitsuya, Yutaka Okuno

Blood (2013) 121 (6): 962–970.

https://doi.org/10.1182/blood-2012-05-431429

Published: 2013

Includes: Supplemental data

Journal Articles

A Novel Approach in Expanding CD34+CD90+ and CD34+CD38-CD90+ Cells Associated with Enhanced in Vivo Repopulating potential.

Hiro Tatetsu, MD, PhD, Chong Gao, MD, PhD, Shikiko Ueno, MD, PhD, Daniel G Tenen, MD, Li Chai, MD

Blood (2012) 120 (21): 2337.

https://doi.org/10.1182/blood.V120.21.2337.2337

Published: 2012

Journal Articles

PU.1-Induced Growth Arrest and Apoptosis in Classical Hodgkin Lymphoma Cells

Hiromichi Yuki, MD, Shikiko Ueno, MD, PhD, Hiroaki Niiro, MD, PhD, Hiro Tatetsu, MD, PhD, Hiroyuki Hata, MD, PhD, Toshiki Watanabe, MD, PhD, Seiji Okada, MD, Ph.D, Koichi Akashi, MD, PhD., Hiroaki Mitsuya, Professor, Yutaka Okuno, MD, PhD

Blood (2011) 118 (21): 2628.

https://doi.org/10.1182/blood.V118.21.2628.2628

Published: 2011

Journal Articles

SALL4 Is a Key Survival Factor in Acute B-Cell Lymphoblastic Leukemia

Shikiko Ueno, MD, PhD, Jiayun Lu, PhD, He Jie, PhD, Ailing Li, PhD, XiaoXian Zhang, Leslie E Silberstein, MD, Jerome Ritz, MD, Li Chai, MD

Blood (2011) 118 (21): 2428.

https://doi.org/10.1182/blood.V118.21.2428.2428

Published: 2011

Journal Articles

Production of TRAIL by Multiple Myeloma Cells: a Potential Prediction Marker for Skeletal-Related Events

Yawara Kawano, Shikiko Ueno, Masahiro Abe, MD, Yoshitaka Kikukawa, Hiromichi Yuki, Kenichi Iyama, Yutaka Okuno, MD, PhD, Hiroaki Mitsuya, Hiroyuki Hata, MD, PhD

Blood (2010) 116 (21): 2975.

https://doi.org/10.1182/blood.V116.21.2975.2975

Published: 2010

Journal Articles

Upregulation of TRAIL in Myeloma Cells Correlates with Skeletal-Related Events.

Yawara Kawano, Shikiko Ueno, Yutaka Okuno, Yoshitaka Kikukawa, Hiroaki Mitsuya, Hiroyuki Hata, MD, PhD

Blood (2009) 114 (22): 2844.

https://doi.org/10.1182/blood.V114.22.2844.2844

Published: 2009

Journal Articles

Conditionally Expressed PU.1 Transactivates TRAIL Gene and Induces Apoptosis in Myeloma Cell Lines.

Shikiko Ueno, Hiro Tatetsu, Hiroyuki Hata, MD, PhD, Tadafumi IIno, Hiroaki Niiro, Koichi Akashi, MD, PhD, Daniel G. Tenen, MD, Hiroaki Mitsuya, Yutaka Okuno

Blood (2008) 112 (11): 1676.

https://doi.org/10.1182/blood.V112.11.1676.1676

Published: 2008

Journal Articles

Microarray Analysis of PU.1-Induced Growth Arrest and Apoptosis of Myeloma Cell Lines.

Shikiko Ueno, Hiro Tatetsu, Naoko Harada, Hiroyuki Hata, Tadafumi Iino, Hiroaki Niiro, Koichi Akashi, Daniel G. Tenen, Hiroaki Mitsuya, Yutaka Okuno

Blood (2007) 110 (11): 2499.

https://doi.org/10.1182/blood.V110.11.2499.2499

Published: 2007

Journal Articles

PU.1 Is Downregulated in a Subset of Multiple Myeloma by the Methylation of Its -17 kb Upstream Regulatory Region and the Promoter.

Yutaka Okuno, MD, PhD, Hiro Tatetsu, MD.PhD., Shikiko Ueno, MD., Hiroyuki Hata, MD.PhD., Yasuhiro Yamada, MD.PhD., Motohiro Takeya, MD.PhD., Tadafumi Iino, MD, Koichi Akashi, MD.PhD., Daniel G. Tenen, MD., Hiroaki Mitsuya, MD.PhD.

Blood (2006) 108 (11): 3417.

https://doi.org/10.1182/blood.V108.11.3417.3417

Published: 2006

NARROW

PU.1-Induced IRF4 Down-Regulation and Subsequent IRF7 up-Regulation in Myeloma Cells

Conditional Knockout of Sfpi1 in Post GC B and Plasma Cells Induces B Cell Lymphoma and Plasma Cell Neoplasm

Xenograft Models of Multiple Myeloma Reveal That PU.1 Serves As a Tumor Suppressor for Multiple Myeloma

SALL4 Is a Key Factor in HDAC Inhibitor Mediated Ex Vivo Expansion of Human Peripheral Blood Mobilized Stem/Progenitor CD34+CD90+ Cells

PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cells

A Novel Approach in Expanding CD34+CD90+ and CD34+CD38-CD90+ Cells Associated with Enhanced in Vivo Repopulating potential.

PU.1-Induced Growth Arrest and Apoptosis in Classical Hodgkin Lymphoma Cells

SALL4 Is a Key Survival Factor in Acute B-Cell Lymphoblastic Leukemia

Production of TRAIL by Multiple Myeloma Cells: a Potential Prediction Marker for Skeletal-Related Events

Upregulation of TRAIL in Myeloma Cells Correlates with Skeletal-Related Events.

Conditionally Expressed PU.1 Transactivates TRAIL Gene and Induces Apoptosis in Myeloma Cell Lines.

Microarray Analysis of PU.1-Induced Growth Arrest and Apoptosis of Myeloma Cell Lines.

PU.1 Is Downregulated in a Subset of Multiple Myeloma by the Methylation of Its -17 kb Upstream Regulatory Region and the Promoter.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only